Cell Journal (Jun 2018)

Correction: COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial

  • Mohammad Hassan Naseri,
  • Hoda Madani,
  • Seyed Hossein Ahmadi Tafti,
  • Maryam Moshkani Farahani,
  • Davood Kazemi Saleh,
  • Hossein Hosseinnejad,
  • Saeid Hosseini,
  • Sepideh Hekmat,
  • Zargham Hossein Ahmadi,
  • Majid Dehghani,
  • Alireza Saadat,
  • Soura Mardpour,
  • Seyedeh Esmat Hosseini,
  • Maryam Esmaeilzadeh,
  • Hakimeh Sadeghian,
  • Gholamreza Bahoush,
  • Ali Bassi,
  • Ahmad Amin,
  • Roghayeh Fazeli,
  • Yaser Sharafi,
  • Leila Arab,
  • Mansour Movahhed,
  • Saeid Davaran,
  • Narges Ramezanzadeh,
  • Azam Kouhkan,
  • Ali Hezavehei,
  • Mehrnaz Namiri,
  • Fahimeh Kashfi,
  • Ali Akhlaghi,
  • Fattah Sotoodehnejadnematalahi,
  • Ahmad Vosough Dizaji,
  • Hamid Gourabi,
  • Naeema Syedi,
  • Abdolhosein Shahverdi,
  • Hossein Baharvand,
  • Nasser Aghdami

DOI
https://doi.org/10.22074/cellj.2018.6018
Journal volume & issue
Vol. 20, no. 3
pp. 449 – 449

Abstract

Read online

This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations (1, 4, 5, and 10) were changed based on authors request.